Search Results
(±)16(17)-EpDPA 100 µg | ≥90%
Cayman Chemical
(±)16(17)-EpDPA 50 µg | ≥90%
Cayman Chemical
(±)16(17)-EpDPA 25 µg | ≥90%
Cayman Chemical
(±)16(17)-EpDPA 1 mg | Purity Not Available
TargetMol
EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.[1],[2]Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as (±)14(15)-EET which are prime candidates for the actual active mediator.[3] However, the CYP450 […]
More Information Supplier Page(±)16(17)-EpDPA 25mg | ≥90%
Musechem
(±)17-HDHA 250 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)17-HDHA 100 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)17-HDHA 50 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)17-HDHA 25 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)17-HDHA 1 mg | Purity Not Available
TargetMol
(±)17-HDHA is an autoxidation product of docosahexaenoic acid in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. 17(S)-HDHA could be produced by enzymatic oxidation of DHA using soybean lipoxygenase (LO) and is the putative product of mammalian 15-LOs. 17(S)-HDHA was shown to be an inhibitor of U-46619 […]
More Information Supplier Page

